Pharmaceutical Intermediates

Tuam txhab Profile

Henan Alfa Chemical Co., Ltd, tau tsim nyob rau hauv Suav teb ntau xyoo dhau los nrog lub hom phiaj ntawm kev muab cov tshuaj zoo rau peb cov neeg siv khoom. Ntau xyoo dhau los, peb tau ua haujlwm tsis tu ncua los txhawb peb lub koob npe nrov raws li tus neeg muag khoom tshuaj lom neeg muaj kev ntseeg siab thiab kev ntseeg siab hauv kev ua lag luam.Thaum ntxov, peb pib los ntawm kev muab cov tshuaj yooj yim rau cov lag luam me. Txawm li cas los xij, raws li peb lub koob npe nrov, yog li peb cov neeg siv khoom thiab ntau yam tshuaj uas peb tau muab. Peb tam sim no txaus siab los muab ntau yam tshuaj xws li cov tshuaj reagents, cov khoom siv tshuaj thiab cov tshuaj lom neeg ua kom tau raws li qhov xav tau ntawm ntau yam kev lag luam & kev tshawb fawb.

 

tuam txhab kom zoo dua

Cov khoom lag luam nplua nuj

Peb lub tuam txhab tuaj yeem tsim cov tshuaj reagents, cov khoom siv tshuaj thiab biochemicals kom tau raws li cov kev xav tau ntawm kev lag luam hauv tsev thiab txawv teb chaws, thiab xa tawm mus rau Tebchaws Meskas, European Union thiab lwm lub tebchaws thiab cheeb tsam, nrog rau cov teb chaws Asia, Africa, thiab Middle East.

Quality Assurance

Peb yog cov chaw tsim khoom lag luam tau lees paub los ntawm FDA, CCE thiab REACH cov qauv. Peb cov khoom yog 100% Hoobkas kuaj thiab zoo ntim. Tag nrho peb cov khoom ua raws li cov qauv kev lag luam xws li CE, ISO, thiab lwm yam.

 

Advanced Instruments

Peb lub tuam txhab muaj cov cuab yeej siv siab tshaj plaws thiab cov cuab yeej siv tshuaj thiab cov cuab yeej siv siab tshaj plaws, xws li kev ua haujlwm siab ua kua chromatography, ntsuas ntsuas ntsuas, UV-pom spectrophotometers, thiab lwm yam.; nws tseem yog nruab nrog cov chaw soj nstuam siab heev uas tuaj yeem tsim tshwj xeeb hauv kev tsim cov tshuaj reagents, cov khoom siv tshuaj, tshuaj muaj tshuaj thiab lwm yam.

Kev Pabcuam

Peb muaj ntau xyoo ntawm kev lag luam kev paub thiab ua tiav kev tswj hwm kev tsim khoom, kev saib xyuas zoo, kev pabcuam kev muag khoom. Txawm hais tias koj xav yuav cov tshuaj reagents sib txawv, lossis lwm yam biochemicals, tsuas yog xa koj cov cai ntawm email thiab peb tuaj yeem kho cov khoom rau koj. Peb kuj txais OEM customization.

Tsev 1234567 Rau sab kawg 1/69

 

Bromophthalide yog dab tsi

Dibromoanisole, tseem hu ua o-methoxybromobenzene, o-bromoanisole, 1-bromo-2-methoxybenzene, o-bromoanisole, methoxy-2-bromobenzene, lus Askiv lub npe 1-Bromo {{7} }methoxybenzene. Cov mis mos molecular C7H7BrO, molecular hnyav 187.03. Lub teeb daj oily kua, insoluble hauv dej, soluble hauv ethanol thiab ether. Toxic, thermal decomposition tso tawm cov pa phem bromide.

CAS:2748017-40-3 | 2H-Benzotriazole, 4,7-dibromo-2-methyl-5,6-dinitro-

 

CAS No.40061-55-0 | Ethyl 3-tolylacetate
Dab tsi yog Daim Ntawv Thov ntawm Bromophthalide

Cov tshuaj tsw qab dianhydride monomer dicarboxyphenoxy pawg uas muaj 5-bromophthalide qauv tau npaj, thiab polymerized nrog bisether diamine muaj trifluoromethyl hloov los npaj cov organic soluble PEI resins. Cov yeeb yaj kiab npaj siv cov khoom siv no muaj qhov pom pom zoo tshaj plaws thiab kev ruaj ntseg kub-resistant, nrog UV txiav tawm wavelengths hauv qab 380nm thiab Tg saum 230 degree. Cov khoom zoo sib xws ua rau lawv muaj kev cia siab rau kev thov hauv thaj chaw kho qhov muag. Qee cov kws sim kuj tau siv 5-bromophthalide derivative-benzopyrrolidone diphenol (cov tshuaj tiv thaiv ntawm phenolphthalein thiab aniline) ua raw khoom los npaj ob npaug ether diamine monomer, thiab tom qab ntawd polymerized nws nrog dianhydride monomer los npaj cov phenolphthalein hloov pauv. PEI. PEI resin no tuaj yeem yaj hauv cov kuab tshuaj polar aprotic, nrog rau cov kuab tshuaj xws li tetrahydrofuran thiab chloroform. PEI zaj duab xis npaj tau zoo thaum tshav kub kub thiab ruaj khov, nrog Tg siab tshaj 240 degree.

Kev piav qhia luv luv ntawm Bromophthalide Market

Bromophthalide yog ib qho tseem ceeb pib cov khoom siv rau kev npaj ntawm cov tshuaj pharmacologically active tshuaj, nrog rau cov tshuaj antidepressant citalopram.Kev tsom xam thiab kev nkag siab: Ntiaj teb no 5-Bromophthalide MarketDue rau COVID-19 muaj thoob qhov txhia chaw, lub ntiaj teb no {{2} }Bromophthalide kev lag luam loj yog kwv yees tias muaj nqis US $ lab hauv 2022 thiab tau kwv yees rau qhov hloov kho loj ntawm US$ lab los ntawm 2028 nrog CAGR ntawm % thaum lub sijhawm tshuaj xyuas. Kev txiav txim siab txog kev hloov pauv nyiaj txiag los ntawm qhov teebmeem kev noj qab haus huv no, 98% Purity accounting rau % ntawm 5-Bromophthalide thoob ntiaj teb kev ua lag luam hauv 2021, yog kwv yees kom muaj nuj nqis US$ lab los ntawm 2028, loj hlob ntawm % CAGR kho nyob rau tom qab-COVID -19 lub sijhawm. Thaum Organic Synthesis ntu tau hloov pauv mus rau % CAGR thoob plaws lub sijhawm kwv yees no.Tuam Tshoj Bromophthalide kev lag luam loj muaj nuj nqis ntawm US$ lab hauv 2021, thaum US thiab Europe Bromophthalide yog US$ lab thiab US$ lab, ntau ntau. Kev faib ua feem ntawm Teb Chaws Asmeskas yog % hauv 2021, thaum Tuam Tshoj thiab Europe yog % thiab % feem, thiab nws tau kwv yees tias Tuam Tshoj feem pua ​​​​ntawm 2028 yuav nce mus txog % hauv 2028, tom qab CAGR ntawm % los ntawm lub sijhawm tshuaj ntsuam.

CAS:346-88-3 | 3,3'-BIS(TRIFLUOROMETHYL)BENZIDINE
CAS No.153259-31-5 | 2-Chloromethyl-4-(3-methoxypropoxy)-3-methylpyridine Hydrochloride
Cia ntawm Bromobenzene Phthalide

Kev khaws cia ntawm bromobenzene phthalide yuav tsum xav txog cov ntsiab lus hauv qab no:
1.Nws yuav tsum tau muab cia rau hauv qhov chaw qhuav thiab qhov cua, tsis txhob ya raws, qhov kub thiab txias, thiab ncaj qha tshav ntuj.

2.Nws yog ib qho tsim nyog los cais thiab khaws cov khoom siv hluav taws xob, tawg, thiab oxidizing los tiv thaiv kev tsim cov khoom phom sij.

3. Kev haus luam yeeb thiab qhib nplaim taws yuav tsum raug txwv nyob rau hauv qhov chaw cia khoom, thiab cov khoom siv tua hluav taws thiab cov chaw tua hluav taws yuav tsum raug teeb tsa.

4. Cov thawv ntim khoom yuav tsum tau sau nrog cov ntaub ntawv xws li lub npe, qauv, qhov hnyav, thiab cov ntsiab lus.

5.Lub sij hawm cia yuav tsum tsis txhob ntev dhau, thiab nws yuav tsum nruj me ntsis khaws cia raws li cov khoom qhia. Thaum lub hnub tas sij hawm dhau mus, nws yuav tsum yog
Ua tam sim ntawd.

Tri-N-Octylaluminium yog dab tsi

Tri-n-octylaluminium yog ib qho sib xyaw ua ke ntawm cov chav kawm ntawm organometallic compounds, tshwj xeeb yog txhuas alkyl. Nws yog siv feem ntau raws li nplaim taws retardant thiab raws li ib tug catalyst nyob rau hauv ntau yam tshuaj tiv thaiv. Trioctylaluminum tuaj yeem siv los ua cov tshuaj siv tshuaj nruab nrab. Yog tias trioctyl aluminium nqus tau, txav tus neeg mob mus rau huab cua ntshiab; Yog tias muaj kev sib cuag ntawm daim tawv nqaij, tshem tawm cov khaub ncaws tsis huv thiab ntxuav cov tawv nqaij kom huv si nrog xab npum thiab dej. Yog tias koj tsis xis nyob, nrhiav kev kho mob; Yog tias qhov muag tshwm sim, cais cov tawv muag yaug nrog dej los yog ntsev thiab nrhiav kev kho mob tam sim ntawd. Yog tias noj, yaug qhov ncauj tam sim ntawd. Tsis txhob ntuav ntuav thiab nrhiav kev kho mob tam sim ntawd.

CAS: 885271-78-3 | 6-Bromo-3-chloro-1H-indazole

 

Cov txiaj ntsig ntawm Tri-N-Octylaluminium

 

Nplaim Retardant siv tau zoo

Tri-N-Octylaluminium ua raws li cov nplaim hluav taws muaj txiaj ntsig vim nws muaj peev xwm tso tawm aluminium oxide thaum cua sov, uas tsim cov txheej txheem tiv thaiv cov khoom siv hluav taws xob, yog li inhibiting kev sib kis ntawm hluav taws.

01

Catalytic Properties

Tri-N-Octylaluminium yog siv los ua cov catalyst hauv cov tshuaj tiv thaiv polymerization, xws li hauv kev tsim cov polyethylene thiab polypropylene. Nws cov kev ua haujlwm catalytic txhim kho cov tshuaj tiv thaiv, ua rau cov txheej txheem ntau lawm thiab muaj peev xwm txo qis kev siv hluav taws xob.

02

Txhim kho cov txheej txheem ntawm Polymers

Raws li ib tug co-catalyst, Tri-N-Octylaluminium tuaj yeem txhim kho cov txheej txheem ntawm cov polymers los ntawm kev pab txhawb kev pib ntawm cov txheej txheem polymerization, uas ua rau cov polymers nrog cov khoom siv zoo dua qub thiab purity.

03

Ntau yam

Tri-N-Octylaluminium tuaj yeem siv rau ntau yam kev siv vim nws muaj peev xwm ua haujlwm nrog ntau hom polymers thiab cov txheej txheem, ua rau nws muaj txiaj ntsig zoo hauv ntau yam kev lag luam.

04

Txo Cov Khoom Muaj Teeb Meem

Piv rau lwm cov nplaim hluav taws, Tri-N-Octylaluminium tuaj yeem suav tias tsis tshua muaj kev phom sij, uas yog qhov zoo rau cov neeg ua haujlwm kev nyab xeeb thiab kev cuam tshuam ib puag ncig.

05

 

Dab tsi yog Daim Ntawv Thov ntawm Tri-N-Octylaluminium

 

 

Tri-n-octyl txhuas tuaj yeem siv los npaj cov khoom siv catalyst rau olefin polymerization, uas muaj Mg, Ti, halogen thiab tus neeg pub khoom siv hluav taws xob, thiab tus neeg pub khoom siv hluav taws xob raug xaiv los ntawm tsawg kawg ib lub nplhaib hloov pauv hauv cov qauv dav dav (I) Ether acid ester compound Qhov kev tsim tawm tam sim no tseem nthuav tawm cov catalyst uas muaj cov khoom siv catalyst thiab siv cov catalyst hauv olefin polymerization, tshwj xeeb tshaj yog nyob rau hauv propylene polymerization. Lub compound uas muaj ib tug tshwj xeeb nplhaib hloov qauv nyob rau hauv cov khoom catalyst tivthaiv tam sim no invention muaj ib tug steric hindrance nyhuv thiab yuav kho lub stereoconfiguration ntawm ether thiab acid ester functional pawg, koom nyob rau hauv lub tsim ntawm lub catalyst active chaw thiab txhim kho lub stereospecificity ntawm lub catalyst. Ua kom muaj txiaj ntsig zoo.

 

Cov yam ntxwv ntawm Tri-N-Octylaluminium

 

Organometallic Xwm

Tri-N-Octylaluminium yog ib qho organometallic compound vim nws muaj ob qho tib si carbon thiab txhuas atoms hauv nws cov qauv. Aluminium atom yog covalently bonded rau peb n-octyl pawg, uas yog cov saw ntev alkyl pawg muab los ntawm octane .

01

Nplaim Retardant Properties

Tri-N-Octylaluminium tso tawm aluminium oxide thaum raug tshav kub, uas ua rau muaj kev tiv thaiv kev tiv thaiv ntawm cov khoom siv, txo lawv cov nplaim taws thiab ua rau kom muaj hluav taws kub.

02

Catalytic Activity

Tri-N-Octylaluminium yog dav siv los ua catalyst, tshwj xeeb tshaj yog nyob rau hauv olefin polymerization txheej txheem. Nws tuaj yeem pib thiab ceev cov polymerization ntawm ethylene thiab propylene los ua polyethylene thiab polypropylene, feem. Qhov kev txiav txim catalytic ntawm Tri-N-Octylaluminium feem ntau txhim kho los ntawm kev siv cov hlau hloov pauv xws li titanium lossis zirconium.

03

Kev ruaj ntseg

Tri-N-Octylaluminium yog qhov ruaj khov nyob rau hauv cov dej tsis muaj dej, tab sis tuaj yeem degrade sai heev thaum raug dej los yog qhov chaw ntub dej. Qhov instability no yuav tsum tau cia thiab tuav nyob rau hauv inert atmospheres, feem ntau qhuav nitrogen los yog argon.Tri-N-Octylaluminium yog soluble nyob rau hauv nonpolar organic solvents, uas tso cai rau nws daim ntawv thov nyob rau hauv kev daws thiab dispersions. Txawm li cas los xij, nws yog feem ntau insoluble hauv dej vim qhov tsis muaj polar xwm ntawm pawg alkyl.

04

 

Tri-n-octylaluminium Kev ua lag luam: Kev sib tw toj roob hauv pes

 

 

Kev sib tw toj roob hauv pes ntawm Tri-n-octylaluminium Market yog ib qho tseem ceeb ntawm peb txoj kev lag luam tsom xam. Peb tau soj ntsuam nruj me ntsis rau cov players tseem ceeb hauv lub npe no los muab cov duab meej ntawm lawv cov tswv yim thiab kev lag luam muaj nyob. Peb daim ntawv tshaj tawm suav nrog kev ntsuam xyuas ntawm cov thawj coj hauv kev lag luam, cov neeg sib tw tawm tshiab, thiab lawv qhov chaw txheeb ze.Los ntawm kev txheeb xyuas SWOT, peb qhia txog qhov muaj zog, qhov tsis muaj zog, lub sijhawm, thiab kev hem thawj los ntawm cov neeg ua lag luam no. Qhov no ua rau cov neeg muaj feem cuam tshuam nrog kev nkag siab tseem ceeb rau kev txiav txim siab zoo.

Peb qhov kev soj ntsuam txuas ntxiv mus rau ntu ntu ntawm Tri-n-octylaluminium Kev Lag Luam, ib qho tseem ceeb rau kev nkag siab txog nws cov kev sib txawv. Peb tau faib cov lag luam raws li cov khoom lag luam, thaj chaw thaj chaw, thiab cov neeg siv khoom noj. Txhua ntu raug tshuaj xyuas los nthuav tawm cov ncauj lus sib txawv, kev cia siab rau kev loj hlob, thiab cov kev cov nyom

 

Difluorobenzophenone yog dab tsi

 

Difluorobenzophenone yog ib qho organic compound nrog cov mis ntawm (FC6H4)2CO. Cov khoom tsis muaj xim no feem ntau yog siv los ua cov khoom ua ntej rau PEEK, lossis polyetherether ketone, uas yog hu ua kev ua haujlwm siab polymer. Vim tias PEEK tiv thaiv kev tawm tsam, feem ntau yog siv rau hauv cov pa roj carbon fiber ntau txheej thiab cov rwb thaiv tsev cable.Difluorobenzophenone yog npaj los ntawm acylation ntawm fluorobenzene nrog p-fluorobenzoyl chloride. Kev hloov pauv feem ntau yog ua nyob rau hauv lub xub ntiag ntawm ib qho txhuas chloride catalyst nyob rau hauv cov roj av ether hnyav.

 

Difluorobenzophenone Txheej txheem ntau lawm

 

 

Siv 4,4-diaminodiphenylmethane ua cov khoom siv raw, fluoroboric acid yog siv los ua ob qho tib si acidic nruab nrab thiab fluorinated raw khoom. Cov molar piv rau cov khoom siv raw yog 6: 1. Ntawm qhov kub ntawm 0 mus rau 5 degree, lub sij hawm dripping ntawm sodium nitrite yog 20 los ua cov tshuaj tiv thaiv diazotization nyob rau hauv cov xwm txheej ntawm 30 feeb; siv cov txheej txheem toluene hnyav ntxiv cov khoom hauv cov khoom siv rau cov tshuaj tiv thaiv decomposition, cov tshuaj tiv thaiv lub sijhawm yog 1 teev; Tom qab ntawd siv 70% dilute nitric acid los ua oxidation cov tshuaj tiv thaiv los ntawm kev poob, lub sij hawm dripping yog 3h, qhov kub thiab txias cov tshuaj tiv thaiv yog 3h, thiab 4 yog tau, 4-difluorobenzophenone cov khoom.

 

 
Dab tsi yog Daim Ntawv Thov ntawm Difluorobenzophenone
 

Hauv kev lag luam kws tshuaj
Raws li cov kws tshuaj nruab nrab, difluorobenzophenone feem ntau yog siv los tsim cov tshuaj muaj zog cerebral vasodilator "Fluorobenzophenone" thiab cov tshuaj tshiab "Dukesi" rau kev kho mob Alzheimer's disease. "Flucarizine" yog cov tshuaj calcium antagonist ntev uas txhim kho cov ntshav ncig hauv lub hlwb cov ntaub so ntswg, txhim kho kev ua siab ntev ntawm lub hlwb rau cov pa oxygen, thiab tiv thaiv cov ntaub so ntswg hlwb thaum siv rau cov kab mob cerebral hypoxic. Nws yog tsuas yog siv los kho kiv taub hau thiab migraine. , tinnitus, nco tsis tau thiab pw tsaug zog atherosclerosis thiab lwm yam mob. DucoXi tam sim no tsuas yog cov tshuaj uas tuaj yeem muab cov pa oxygen ntau ntxiv rau lub hlwb thiab cov paj hlwb los ntawm kev ua kom cov hlab ntsha oxygen ib nrab siab. DucoXi lub cim tshwj xeeb ntawm kev ua kom cov pa oxygen tso cai rau nws los kho lub hlwb thiab cov paj hlwb, uas yog cov kabmob uas nkag siab zoo rau hypoxia. Nws qhia tau hais tias cov nyhuv curative zoo heev thaum muaj kev ua haujlwm tsis zoo, thiab feem ntau yog siv los kho cov tsos mob neurological dementia tshwm sim los ntawm mob stroke, thiab lwm yam hauv cov neeg laus.

 

Hauv engineering plastics
Difluorobenzophenone yog cov khoom siv tseem ceeb siv los ua cov khoom siv tshiab uas muaj ntxhiab thermoplastic engineering yas polyetheretherketone (PEEK), uas yog ib hom tshiab ntawm semi-crystalline aromatic thermoplastic engineering yas. Hauv ntau qhov tshwj xeeb, nws tuaj yeem hloov cov khoom siv ib txwm muaj xws li hlau thiab ceramics, thiab tshwj xeeb tshaj yog nyob rau hauv kev txo cov huab hwm coj thiab txhim kho kev ua haujlwm. Ua ib qho ntawm cov khoom siv hluav taws xob zoo tshaj plaws niaj hnub no. Ntau lub tsev tshawb fawb kev tshawb fawb hauv tsev tau tshawb fawb ntau yam ntawm daim ntawv thov thiab kev hloov pauv ntawm polyether ether ketone, qhia txog kev txhim kho zoo. Raws li kev pom ntawm cov khoom zoo ntawm polyetheretherketone, nws feem ntau yog siv hauv aerospace, tsheb thiab lwm qhov chaw uas yuav tsum tau yas los hloov cov hlau. Nws kuj yog siv dav hauv electronics thiab hluav taws xob, precision instrumentation thiab lwm yam. Cov koom haum txawv teb chaws tau kwv yees tias qhov kev loj hlob txhua xyoo ntawm lub ntiaj teb PEEK yuav nyob ib ncig ntawm 20% txij xyoo 2002 txog 2007. Ib qho ntawm cov yuam sij rau kev tsim cov polyetheretherketone yog cov synthesis thiab zus tau tej cov 4,4'-difluorobenzophenone.

 

 

Cov yam ntxwv ntawm Difluorobenzophenone

 

Lub difluorobenzophenone yog cov reactive heev, muaj peev xwm koom nrog ntxiv cov tshuaj tiv thaiv, xws li nucleophilic acyl hloov.

 

Cov fluorine atoms nce lub electrophilicity ntawm lub nplhaib aromatic vim yog -I nyhuv (inductive tshem tawm ntawm electron ceev), ua rau nws ntau reactive rau electrophilic aromatic hloov tshuaj.

 

Cov CF daim ntawv cog lus yog qhov ruaj khov thiab tiv taus hydrolysis, uas tuaj yeem muab kev ruaj ntseg metabolic rau cov tshuaj uas muaj cov moiety.

 

Peb lub Hoobkas

 

 

Henan Alfa Chemical Co., Ltd, tau tsim nyob rau hauv Suav teb ntau xyoo dhau los nrog lub hom phiaj ntawm kev muab cov tshuaj zoo rau peb cov neeg siv khoom. Ntau xyoo dhau los, peb tau ua haujlwm tsis tu ncua los txhawb peb lub koob npe nrov raws li tus neeg muag khoom tshuaj lom neeg muaj kev ntseeg siab thiab kev ntseeg siab hauv kev ua lag luam.Thaum ntxov, peb pib los ntawm kev muab cov tshuaj yooj yim rau cov lag luam me. Txawm li cas los xij, raws li peb lub koob npe nrov, yog li peb cov neeg siv khoom thiab ntau yam tshuaj uas peb tau muab. Peb tam sim no txaus siab los muab ntau yam tshuaj xws li cov tshuaj reagents, cov khoom siv tshuaj thiab cov tshuaj lom neeg ua kom tau raws li qhov xav tau ntawm ntau yam kev lag luam & kev tshawb fawb.

 

 
Peb Cov Khoom
 

 

productcate-1-1productcate-1-1productcate-1-1productcate-1-1

 

 
FAQ
 
 

Q: Dab tsi yog 4 4 Difluorobenzophenone siv rau?

A: 4,4'-Difluorobenzophenone tau siv rau hauv kev kawm txog thermal stability, dej uptake thiab proton conductivity ntawm carboxylated, carboxylated / sulfonated, thiab crosslinked membranes.Cov tshuaj no yog siv los ntawm cov neeg siv khoom, hauv cov khoom, hauv kev tsim lossis rov ntim khoom. thiab ntawm qhov chaw muaj kev lag luam.

Q: Dab tsi yog kev siv ntawm 2 4 Dibromophenol?

A: 2,4-DBP nrhiav tau daim ntawv thov raws li ib tug reactive intermediate nyob rau hauv ib tug epoxy-phenolic polymer [138] thaum 2,4,6-TBP plays lub luag hauj lwm tseem ceeb raws li ib tug reactive FR, tshuaj intermediate thaum lub sij hawm lub synthesis ntawm brominated nplaim taws retardants nyob rau hauv resins thiab yog ntxiv siv tshuaj tua kab [33,139,140].

Q: Dab tsi yog kev siv ntawm 2 4 Difluoroaniline?

A: 2, 4-difluoroaniline yog ib qho tseem ceeb nruab nrab siv hauv cov organic synthesis, tshuaj agrochemicals, dyes, thiab tshuaj ua liaj ua teb.

Q: Dab tsi yog 2 4 difluoro benzophenone?

A: 2,4'-Difluorobenzophenone yog ib qho reactant nyob rau hauv lub synthesis ntawm EP1 receptor antagonists rau kev kho mob ntawm overactive zais zis. Kuj tseem siv rau hauv kev tsim thiab kev sib txuas ntawm thiosemicarbazone cathespin L inhibitors.

Q: 4 nitrodiphenyl siv rau dab tsi?

A: 4-Nitrobiphenyl yog dawb mus rau daj crystalline (xuab zeb-zoo li) khoom. Nws yog siv los ua plasticizer, fungicide, ntoo preservative thiab dye intermediate. * 4-Nitrobiphenyl yog nyob rau hauv Daim Ntawv Teev Npe Tshuaj Zoo Mob vim tias nws tau tswj hwm los ntawm OSHA thiab suav los ntawm ACGIH, NIOSH, DEP, IARC, NFPA thiab EPA.

Q: Dab tsi yog 2 4 6 tribromotoluene siv rau?

A: 2,4,6-Tribromotoluene, yog siv los ua tshuaj thiab cov organic nruab nrab. Nws tuaj yeem siv los tsim 2,4,6-tribromo-benzyl bromide ntawm qhov kub ntawm 200 - 220 degree . Insoluble hauv dej. Khaws rau hauv qhov chaw txias.

Q: 4 chloro 4 hydroxy benzophenone yog dab tsi?

A: Chloro-4'-hydroxybenzophenone (Fenofibrate EP Impurity A; Fenofibrate USP Related Compound A) lub impurity ntawm Fenofibric acid (42017-89-0), cov metabolite nquag ntawm fenofibrate uas nce Apolipoprotein AI-Mediated High-Density Lipoprotein Biogenesis los ntawm kev txhim kho cov ntaub ntawv ntawm ATP-Binding cassette.

Q: Cov tshuaj intermediates yog dab tsi?

A: Pharmaceutical intermediates thiab chemical compounds tau siv dav hauv kev tsim ntau hom tshuaj siv tshuaj (APIs) hauv ntau ntau. Lawv kuj tseem muaj txiaj ntsig rau kev tshawb fawb thiab kev txhim kho rau cov khoom siv tshuaj tshiab.

Q: Qhov txawv ntawm API thiab intermediates yog dab tsi?

A: API tsis yog tsim los ntawm ib qho tshuaj tiv thaiv los ntawm cov ntaub ntawv raw tab sis nws dhau los ua API ntawm ntau cov tshuaj sib xyaw. Cov tshuaj sib xyaw ua ke uas yog nyob rau hauv tus txheej txheem ntawm kev ua API los ntawm cov khoom siv raw yog hu ua intermediate.Intermediates thiab cov tshuaj zoo raug noj nyob rau ntau theem ntawm cov saw muaj nuj nqis, xws li cov khoom tseem ceeb los yog cov kauj ruam nruab nrab hauv ntau qhov. txheej txheem kev tsim khoom.

Q: Dab tsi yog qhov tshuaj nruab nrab?

A: Cov tshuaj intermediates yog cov tshuaj siv los ua cov khoom siv raw rau kev tsim cov tshuaj ntau, lossis lawv tuaj yeem xa mus rau cov khoom tsim thaum lub sijhawm sib txuas ntawm API uas yuav tsum tau hloov pauv ntxiv lossis ua tiav ua ntej nws dhau los ua API.A Pharmaceutical Formulation Intermediate ( los yog PFI) yog ib qho kev sib xyaw ntawm cov tshuaj nquag thiab cov khoom ntxiv, feem ntau nyob rau hauv daim ntawv hmoov. Ib qho Active Pharmaceutical Ingredient (los yog API), ntawm qhov tod tes, yog cov tshuaj nquag ntawm cov tshuaj uas ua rau cov tsos mob ntawm tus kab mob.

Q: API intermediaries yog dab tsi?

A: APIs yog ib qho software tivthaiv uas ua haujlwm nruab nrab ntawm ob daim ntawv thov kev sib txuas. Thaum cov kev pabcuam hauv web kuj txuas cov ntawv thov, lawv xav tau lub network ua li ntawd. Qhov twg qee qhov APIs yog qhov qhib, cov kev pabcuam hauv web feem ntau yog tus kheej thiab tsuas yog cov neeg koom tes pom zoo tuaj yeem nkag mus rau lawv.

Q: Dab tsi yog Advanced intermediate hauv pharma?

A: Advanced intermediates yog cov ntaub ntawv qib siab ntawm cov tshuaj intermediates. Advanced intermediate tshuaj yog siv los ua cov tshuaj sib cuam tshuam cov tshuaj uas tsim nyob rau hauv cov khoom siv tshuaj tshiab.

Q: Dab tsi yog active tshuaj cov khoom xyaw APIs thiab intermediates?

A: Cov khoom xyaw tshuaj nquag (APIs) yog cov khoom siv hauv cov tshuaj siv tshuaj uas tsim nyog rau lub cev los kho tus mob. APIs yog tsim los ntawm kev ua cov tshuaj sib xyaw ua ke. Hauv cov tshuaj biologic, cov khoom xyaw nquag hu ua bulk process intermediate (BPI).

Q: Qhov txawv ntawm API thiab kev tsim qauv yog dab tsi?

A: API stands rau Active Pharmaceutical Ingredient thiab nws qhia txog cov khoom xyaw nquag hauv cov tshuaj. Formulation tiav yog txoj kev siv los sib tov cov khoom xyaw los ua ib qho tshuaj. Lub tuam txhab tshuaj lag luam loj feem ntau cuam tshuam nrog txog 200 txog 250 tus neeg xa khoom ntawm API tsim thoob plaws ntiaj teb.

Q: Qhov txawv ntawm API thiab tshuaj yog dab tsi?

A: Cov khoom siv tshuaj, tseem hu ua cov khoom siv tshuaj nquag (API), yog cov tshuaj lom neeg tshwj xeeb lossis cov molecule hauv cov khoom siv tshuaj uas muab cov txiaj ntsig kho mob. Nws yog lub active ingredient lub luag hauj lwm rau cov tshuaj lub pharmacological kev ua ub no.

Q: Cov tshuaj intermediates yog dab tsi?

A: Pharmaceutical intermediates thiab chemical compounds tau siv dav hauv kev tsim ntau hom tshuaj siv tshuaj (APIs) hauv ntau ntau. Lawv kuj tseem muaj txiaj ntsig rau kev tshawb fawb thiab kev txhim kho rau cov khoom siv tshuaj tshiab.

Q: Qhov txawv ntawm API thiab intermediates yog dab tsi?

A: API tsis yog tsim los ntawm ib qho tshuaj tiv thaiv los ntawm cov ntaub ntawv raw tab sis nws dhau los ua API ntawm ntau cov tshuaj sib xyaw. Cov tshuaj sib xyaw ua ke uas yog nyob rau hauv tus txheej txheem ntawm kev ua API los ntawm cov khoom siv raw yog hu ua intermediate.Intermediates thiab cov tshuaj zoo raug noj nyob rau ntau theem ntawm cov saw muaj nuj nqis, xws li cov khoom tseem ceeb los yog cov kauj ruam nruab nrab hauv ntau qhov. txheej txheem kev tsim khoom.

Q: Puas yog tshuaj nruab nrab?

A: Cov tshuaj intermediates yog cov tshuaj siv los ua cov khoom siv raw rau kev tsim cov tshuaj ntau, lossis lawv tuaj yeem xa mus rau cov khoom tsim thaum lub sijhawm sib txuas ntawm API uas yuav tsum tau hloov pauv ntxiv lossis ua tiav ua ntej nws dhau los ua API.A Pharmaceutical Formulation Intermediate ( los yog PFI) yog ib qho kev sib xyaw ntawm cov tshuaj nquag thiab cov khoom ntxiv, feem ntau nyob rau hauv daim ntawv hmoov. Ib qho Active Pharmaceutical Ingredient (los yog API), ntawm qhov tod tes, yog cov tshuaj nquag ntawm cov tshuaj uas ua rau cov tsos mob ntawm tus kab mob.

Q: API intermediaries yog dab tsi?

A: APIs yog ib qho software tivthaiv uas ua haujlwm nruab nrab ntawm ob daim ntawv thov kev sib txuas. Thaum cov kev pabcuam hauv web kuj txuas cov ntawv thov, lawv xav tau lub network ua li ntawd. Qhov twg qee qhov APIs yog qhov qhib, cov kev pabcuam hauv lub vev xaib feem ntau yog ntiag tug thiab tsuas yog cov neeg koom tes pom zoo tuaj yeem nkag mus rau lawv.Active pharmaceutical ingredients (APIs) yog cov khoom siv hauv cov tshuaj uas tsim nyog rau lub cev los kho tus mob. APIs yog tsim los ntawm kev ua cov tshuaj sib xyaw ua ke. Hauv cov tshuaj biologic, cov khoom xyaw nquag hu ua bulk process intermediate (BPI).

Q: Dab tsi yog Advanced intermediate hauv pharma?

A: Advanced intermediates yog cov ntaub ntawv qib siab ntawm cov tshuaj intermediates. Advanced intermediate tshuaj yog siv los ua cov tshuaj sib cuam tshuam cov tshuaj uas tsim nyob rau hauv cov khoom siv tshuaj tshiab.API stands rau Active Pharmaceutical Ingredient thiab nws qhia txog cov khoom xyaw nquag hauv cov tshuaj. Formulation tiav yog txoj kev siv los sib tov cov khoom xyaw los ua ib qho tshuaj. Lub tuam txhab tshuaj lag luam loj feem ntau cuam tshuam nrog txog 200 txog 250 tus neeg xa khoom ntawm API tsim thoob plaws ntiaj teb.

Q: Dab tsi yog active tshuaj cov khoom xyaw APIs thiab intermediates?

A: Cov khoom siv tshuaj, tseem hu ua cov khoom siv tshuaj nquag (API), yog cov tshuaj lom neeg tshwj xeeb lossis cov molecule hauv cov khoom siv tshuaj uas muab cov txiaj ntsig kho mob. Nws yog lub active ingredient lub luag hauj lwm rau cov tshuaj lub pharmacological kev ua ub no.

Peb paub zoo tias yog ib qho ntawm cov kws tshuaj intermediates manufacturers hauv Suav teb, tshwj xeeb hauv kev muab cov khoom lag luam zoo. Thov so assured mus yuav cov tshuaj intermediates ua nyob rau hauv Suav teb nov los ntawm peb lub hoobkas.

whatsapp

Xov tooj

Tug

Kev nug

hnab